Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott P Runyon

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Pharmacology and Experimental Therapeutics|March 15, 2018
Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in RatsMichael D Raleigh, Megan Laudenbach, Federico Baruffaldi, et al.
Bioorganic & Medicinal Chemistry Letters|December 16, 2014
Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2James B Thomas, Angela M Giddings, Srinivas Olepu, et al.
Bioorganic & Medicinal Chemistry|December 25, 2012
Enhanced bioactivity of silybin B methylation productsArlene A Sy-Cordero, Tyler N Graf, Scott P Runyon, et al.
Journal of Medicinal Chemistry|April 25, 2018
Blocking Alcoholic Steatosis in Mice with a Peripherally Restricted Purine Antagonist of the Type 1 Cannabinoid ReceptorGeorge S Amato, Amruta Manke, Danni L Harris, et al.
Journal of Medicinal Chemistry|July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Journal of Medicinal Chemistry|August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Bioconjugate Chemistry|March 17, 2025
Bivalent Hapten Display Strategies for Conjugate Vaccines Targeting Opioid Mixtures Containing FentanylCarly Baehr, Rajwana Jahan, Ann Gebo, et al.
Bioorganic & Medicinal Chemistry|March 10, 2005
Synthesis, structural identification, and ligand binding of tropane ring analogs of paroxetine and an unexpected aza-bicyclo[3.2.2]nonane rearrangement productScott P Runyon, Jason P Burgess, Philip Abraham, et al.
ACS Chemical Neuroscience|July 1, 2016
Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2James B Thomas, Mélanie Vivancos, Angela M Giddings, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2025
An antifentanyl monoclonal antibody reverses fentanyl-induced apnea in pigsCarly Baehr, Eduardo Hatschbach, Jennifer Vigliaturo, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Pharmacology and Experimental Therapeutics|March 15, 2018
Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in RatsMichael D Raleigh, Megan Laudenbach, Federico Baruffaldi, et al.
Bioorganic & Medicinal Chemistry Letters|December 16, 2014
Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2James B Thomas, Angela M Giddings, Srinivas Olepu, et al.
Bioorganic & Medicinal Chemistry|December 25, 2012
Enhanced bioactivity of silybin B methylation productsArlene A Sy-Cordero, Tyler N Graf, Scott P Runyon, et al.
Journal of Medicinal Chemistry|April 25, 2018
Blocking Alcoholic Steatosis in Mice with a Peripherally Restricted Purine Antagonist of the Type 1 Cannabinoid ReceptorGeorge S Amato, Amruta Manke, Danni L Harris, et al.
Journal of Medicinal Chemistry|July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Journal of Medicinal Chemistry|August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Bioconjugate Chemistry|March 17, 2025
Bivalent Hapten Display Strategies for Conjugate Vaccines Targeting Opioid Mixtures Containing FentanylCarly Baehr, Rajwana Jahan, Ann Gebo, et al.
Bioorganic & Medicinal Chemistry|March 10, 2005
Synthesis, structural identification, and ligand binding of tropane ring analogs of paroxetine and an unexpected aza-bicyclo[3.2.2]nonane rearrangement productScott P Runyon, Jason P Burgess, Philip Abraham, et al.
ACS Chemical Neuroscience|July 1, 2016
Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2James B Thomas, Mélanie Vivancos, Angela M Giddings, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2025
An antifentanyl monoclonal antibody reverses fentanyl-induced apnea in pigsCarly Baehr, Eduardo Hatschbach, Jennifer Vigliaturo, et al.
Pageof 5